CENTRAL NERVOUS SYSTEM DEPRESSANT ACTIVITY OF  MA1337, 3-(3-(4-M-CHLOROPHENYL-1-PIPERAZYL)PROPYL)-2,4(1H,3H)QUINAZOLINEDIONE HYDROCHLORIDE.
D000661:Amphetamine; D000662:Amphetamines; D001522:Behavior, Animal; D001831:Body Temperature; D002375:Catalepsy; D002415:Cats; D002490:Central Nervous System; D002492:Central Nervous System Depressants; D002707:Chlordiazepoxide; D002746:Chlorpromazine; D004285:Dogs; D006591:Hexobarbital; D006993:Hypnotics and Sedatives; D008620:Meprobamate; D051379:Mice; D010600:Pharmacology; D010634:Phenobarbital; D011799:Quinazolines; D052999:Quinazolinones; D012106:Research; D012631:Secobarbital; D014116:Toxicology
D000662:Amphetamines; D002492:Central Nervous System Depressants; D006993:Hypnotics and Sedatives; D011799:Quinazolines; D052999:Quinazolinones; D012631:Secobarbital; D002707:Chlordiazepoxide; D008620:Meprobamate; D006591:Hexobarbital; D000661:Amphetamine; D002746:Chlorpromazine; D010634:Phenobarbital
AMPHETAMINE; BEHAVIOR, ANIMAL; BODY TEMPERATURE; CATALEPSY; CATS; CENTRAL NERVOUS SYSTEM; CHLORDIAZEPOXIDE; CHLORPROMAZINE; DOGS; EXPERIMENTAL LAB STUDY; HEXOBARBITAL; HYPNOTICS AND SEDATIVES; MEPROBAMATE; MICE; PHARMACOLOGY; PHENOBARBITAL; QUINAZOLINES; SECOBARBITAL; TOXICOLOGIC REPORT